| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on May 13, 2004
Accepted on June 23, 2004
Cerebral Plasticity Laboratory, FRE-2693 CNRS, University of Montpellier II, Place Eugène Bataillon, 34095 Montpellier, France; Biology of Endocrine Neurons Laboratory, UMR-5101 CNRS, Center of Pharmacology and Endocrinology, 141 Rue de la Cardonille, 34094 Montpellier, France
* To whom correspondence should be addressed. E-mail: aranci{at}univ-montp2.fr.
The median eminence (ME) is considered as the final common pathway connecting the nervous and endocrine systems. In this neurohemal structure, dynamic interactions between nerve terminals, tanycytes and astrocytes determine through plastic processes, the neurohormones access to the portal blood. Since BDNF is involved in plastic changes we investigated its presence and that of its receptors (TrkB) in the different cellular types described in the ME. Using in situ hybridization and immunohistochemical techniques, we demonstrated that BDNF immunoreactivity was essentially located in the astrocytes and to a lesser extent in tanycytes. By contrast, BDNF was not detected in nerve terminals reaching the external layer of the ME. TrkB antibodies recognizing the extracellular receptor domain, labeled all of these different cell types suggesting an autocrine or paracrine action of BDNF at this level. More selective antibodies showed that TrkB.FL immunostaining was found in tanycytes and nerve endings, whereas TrkB.T1 immunostaining was localized in all of cellular types. Immobilization stress increased BDNF mRNA and BDNF immunoreactivity patterns and induced biphasic BDNF release from the ME, as analyzed by push-pull perfusion. In addition, we observed that 60-min stress intensified BDNF immunoreactivity in the internal layer and also its co-localization with GFAP. Stress also accentuated BDNF immunostaining in the perivascular space in elements that were not labeled with antibodies recognizing fibroblast or endothelial cells. These data disclosed a novel location of BDNF and of its receptors in the ME, which are presumably involved in dynamic processes such as hormone release.
This article has been cited by other articles:
![]() |
K. Tsukinoki, J. Saruta, N. Muto, K. Sasaguri, S. Sato, N. Tan-Ishii, and Y. Watanabe Submandibular Glands Contribute to Increases in Plasma BDNF Levels J. Dent. Res., March 1, 2007; 86(3): 260 - 264. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tsukinoki, J. Saruta, K. Sasaguri, Y. Miyoshi, Y. Jinbu, M. Kusama, S. Sato, and Y. Watanabe Immobilization Stress Induces BDNF in Rat Submandibular Glands J. Dent. Res., September 1, 2006; 85(9): 844 - 848. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Gill and P.-S. Tsai Expression of a Dominant Negative FGF Receptor in Developing GNRH1 Neurons Disrupts Axon Outgrowth and Targeting to the Median Eminence Biol Reprod, March 1, 2006; 74(3): 463 - 472. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |